{"name": "Gilead Sciences",
 "permalink": "gilead-sciences",
 "crunchbase_url": "http://www.crunchbase.com/company/gilead-sciences",
 "homepage_url": "http://www.gilead.com/",
 "blog_url": "http://gileadyeffett.wordpress.com/",
 "blog_feed_url": "",
 "twitter_username": "GileadSciences",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1987,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "(650) 574-3000",
 "description": "",
 "created_at": "Sat Jun 26 02:56:53 UTC 2010",
 "updated_at": "Sun Apr 21 11:08:29 UTC 2013",
 "overview": "\u003Cp\u003EGilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases.\u003C/p\u003E\n\n\u003Cp\u003EGilead\u00e2\u20ac\u2122s primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.\u003C/p\u003E\n\n\u003Cp\u003EThere portfolio of 13 marketed products includes a number of category firsts and market leaders, including Atripla\u00c2\u00ae (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) - the first single-tablet regimen for HIV infection. The company\u00e2\u20ac\u2122s first product for HIV infection, Viread\u00c2\u00ae (tenofovir disoproxil fumarate), has also more recently been approved for the treatment of chronic hepatitis B. Chronic hepatitis B, a serious liver disease caused by the hepatitis B virus, is the leading cause of liver cancer worldwide and affects an estimated two million individuals in the United States.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0009/1771/91771v1-max-150x150.png"],
     [[185,
       51],
      "assets/images/resized/0009/1771/91771v1-max-250x250.png"],
     [[185,
       51],
      "assets/images/resized/0009/1771/91771v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman and CEO, President and Chief Executive Officer",
    "person":
     {"first_name": "John",
      "last_name": "C. Martin",
      "permalink": "john-c-martin",
      "image":
       {"available_sizes":
         [[[139,
            135],
           "assets/images/resized/0025/3528/253528v1-max-150x150.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3528/253528v1-max-250x250.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3528/253528v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Vice President and Chief Financial Officer",
    "person":
     {"first_name": "Robin",
      "last_name": "L. Washington",
      "permalink": "robin-l-washington",
      "image":
       {"available_sizes":
         [[[139,
            135],
           "assets/images/resized/0025/3537/253537v1-max-150x150.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3537/253537v1-max-250x250.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3537/253537v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "President and COO,Chief Financial Officer, Director of Project Management and Project Team Leader",
    "person":
     {"first_name": "John",
      "last_name": "F. Milligan",
      "permalink": "john-f-milligan",
      "image":
       {"available_sizes":
         [[[139,
            135],
           "assets/images/resized/0025/3530/253530v1-max-150x150.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3530/253530v1-max-250x250.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3530/253530v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Executive Vice President, Commercial Operations",
    "person":
     {"first_name": "Kevin",
      "last_name": "Young CBE",
      "permalink": "kevin-young-cbe",
      "image":
       {"available_sizes":
         [[[139,
            135],
           "assets/images/resized/0025/3535/253535v1-max-150x150.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3535/253535v1-max-250x250.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3535/253535v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Executive Vice President, Research and Development and Chief Scientific Officer",
    "person":
     {"first_name": "Norbert",
      "last_name": "W. Bischofberger",
      "permalink": "norbert-w-bischofberger",
      "image":
       {"available_sizes":
         [[[139,
            135],
           "assets/images/resized/0025/3531/253531v1-max-150x150.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3531/253531v1-max-250x250.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3531/253531v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Executive Vice President, Corporate and Medical Affairs, General Counsel, Associate General Counsel, Attorney",
    "person":
     {"first_name": "Gregg",
      "last_name": "H. Alton",
      "permalink": "gregg-h-alton",
      "image":
       {"available_sizes":
         [[[139,
            135],
           "assets/images/resized/0025/3533/253533v1-max-150x150.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3533/253533v1-max-250x250.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3533/253533v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Jacqueline",
      "last_name": "K. Barton",
      "permalink": "jacqueline-k-barton",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President, Human Resources",
    "person":
     {"first_name": "Katie",
      "last_name": "L. Watson",
      "permalink": "katie-l-watson",
      "image":
       {"available_sizes":
         [[[139,
            135],
           "assets/images/resized/0025/3538/253538v1-max-150x150.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3538/253538v1-max-250x250.jpg"],
          [[139,
            135],
           "assets/images/resized/0025/3538/253538v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Advisor",
    "person":
     {"first_name": "Louis",
      "last_name": "Lange",
      "permalink": "louis-lange",
      "image":
       {"available_sizes":
         [[[150,
            99],
           "assets/images/resized/0026/7118/267118v1-max-150x150.jpg"],
          [[248,
            165],
           "assets/images/resized/0026/7118/267118v1-max-250x250.jpg"],
          [[248,
            165],
           "assets/images/resized/0026/7118/267118v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Vice President, Commercial Strategy",
    "person":
     {"first_name": "Howard",
      "last_name": "B. Rosen",
      "permalink": "howard-b-rosen",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0025/7882/257882v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7882/257882v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7882/257882v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Regulatory Affairs",
    "person":
     {"first_name": "Margaret",
      "last_name": "Dillon",
      "permalink": "margaret-dillon",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/3864/253864v1-max-150x150.jpg"],
          [[170,
            170],
           "assets/images/resized/0025/3864/253864v1-max-250x250.jpg"],
          [[170,
            170],
           "assets/images/resized/0025/3864/253864v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Research Scientist",
    "person":
     {"first_name": "Wenjin",
      "last_name": "Yang",
      "permalink": "wenjin-yang",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0025/7889/257889v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7889/257889v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7889/257889v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Director HR \u0026 Admin",
    "person":
     {"first_name": "Barbara",
      "last_name": "E. Baring",
      "permalink": "barbara-e-baring",
      "image":
       {"available_sizes":
         [[[99,
            150],
           "assets/images/resized/0025/5256/255256v1-max-150x150.jpg"],
          [[166,
            250],
           "assets/images/resized/0025/5256/255256v1-max-250x250.jpg"],
          [[166,
            250],
           "assets/images/resized/0025/5256/255256v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 120000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/gilead-buy-cgi-pharm-120m/2010-06-25?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Gilead to buy CGI Pharm for $120M",
    "acquired_year": 2010,
    "acquired_month": 6,
    "acquired_day": 25,
    "company":
     {"name": "CGI Pharmaceuticals",
      "permalink": "cgi-pharmaceuticals",
      "image": null}},
   {"price_amount": 225000000.0,
    "price_currency_code": "USD",
    "term_code": "cash",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020101221e6cl0005l\u0026r=Rss\u0026s=DJFVLS",
    "source_description": "  Gilead Sciences To Acquire Arresto BioSciences For $225M Cash",
    "acquired_year": 2010,
    "acquired_month": 12,
    "acquired_day": 20,
    "company":
     {"name": "Arresto BioSciences",
      "permalink": "arresto-biosciences",
      "image":
       {"available_sizes":
         [[[150,
            83],
           "assets/images/resized/0011/4868/114868v1-max-150x150.png"],
          [[250,
            139],
           "assets/images/resized/0011/4868/114868v1-max-250x250.png"],
          [[387,
            216],
           "assets/images/resized/0011/4868/114868v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": 375000000.0,
    "price_currency_code": "USD",
    "term_code": "cash_and_stock",
    "source_url": "http://investors.gilead.com/preview/phoenix.zhtml?c=69964\u0026p=irol-newsArticle\u0026ID=1531190\u0026highlight=",
    "source_description": "Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million",
    "acquired_year": 2011,
    "acquired_month": 2,
    "acquired_day": 22,
    "company":
     {"name": "Calistoga Pharmaceuticals",
      "permalink": "calistoga-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            85],
           "assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],
          [[217,
            124],
           "assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],
          [[217,
            124],
           "assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "333 Lakeside Drive",
    "address2": "",
    "zip_code": "94404",
    "city": "Foster City",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:GILD"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}